Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer (Silhouette)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Van Londen, Gijsberta, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01080170
First received: March 2, 2010
Last updated: December 3, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)